Recombinant Brugia malayi Nucleoside diphosphate kinase (NDK)
Description
Definition and Biochemical Properties
Recombinant Brugia malayi NDK is a 167-amino acid enzyme (18 kDa) produced in Escherichia coli with an N-terminal His-tag for purification . It catalyzes the transfer of phosphate groups between nucleoside diphosphates (e.g., GTP → ATP), ensuring nucleotide balance essential for DNA/RNA synthesis and energy metabolism .
Key Properties of rBmNDK
| Property | Details |
|---|---|
| Molecular Weight | 18 kDa (non-glycosylated) |
| Purity | >95% (SDS-PAGE) |
| Expression System | E. coli |
| Storage Conditions | 4°C (short-term), -20°C (long-term with 0.1% HSA/BSA carrier protein) |
| Activity Buffer | 20 mM Tris-HCl (pH 8.0), 10% glycerol, 0.1 M NaCl, 1 mM DTT |
Functional Characterization
rBmNDK is constitutively expressed across B. malayi life stages, suggesting its essential role in parasite survival . Functional studies highlight:
-
Catalytic Mechanism: Phosphorylates GDP bound to GTP-binding proteins like ARF (ADP-ribosylation factor), enabling GTP-dependent signaling without nucleotide exchange .
-
Enzyme Kinetics: Comparative studies with human NDK reveal structural differences in substrate-binding regions, which could be exploited for selective inhibitor design .
Drug Target Potential
rBmNDK is a candidate for antifilarial drug development due to:
-
Substrate Specificity: Unique binding pockets for nucleotides compared to human NDK .
-
Gene Essentiality: Knockdown of NDK homologs in related nematodes disrupts motility and viability .
Diagnostic Utility
-
Antigenic Cross-Reactivity: NDK homologs in Wuchereria bancrofti and Onchocerca volvulus suggest utility in pan-filarial diagnostic assays .
-
Housekeeping Gene: Used as a normalization control in RT-PCR studies due to stable expression across parasite stages .
Comparative Kinetic Data
| Parameter | rBmNDK (Inferred) | Human NDK | Source |
|---|---|---|---|
| (GDP) | ~10–20 μM | 15–30 μM | |
| 30–40 s⁻¹ | 50–60 s⁻¹ | ||
| Mg²⁺ Dependency | Required | Required |
Challenges and Future Directions
-
Structural Resolution: X-ray crystallography of rBmNDK is needed to map active-site residues for inhibitor design.
-
In Vivo Validation: Testing NDK inhibitors in animal models of filariasis remains unexplored.
-
Cross-Species Studies: Comparative analysis with NDK from Wolbachia (symbiont of B. malayi) could uncover synergistic drug targets .
Product Specs
Target Background
Q&A
Basic Research Questions
-
What is Brugia malayi Nucleoside diphosphate kinase and what is its primary function in the parasite?
Brugia malayi Nucleoside diphosphate kinase (BmNDK) is a key metabolic enzyme that catalyzes the reversible transfer of terminal phosphate groups from nucleoside triphosphates (primarily ATP) to nucleoside diphosphates. In Brugia malayi, this enzyme plays a crucial role in maintaining intracellular di- and tri-phosphate nucleoside homeostasis .
BmNDK has been identified as an immunodominant clone (BmG4-7) through immunoscreening of a B. malayi infective-stage SL cDNA expression library with rabbit anti-infective-stage antibodies. The enzyme contains a full-length cDNA with significant sequence similarity to NDK-encoding sequences from various species including Drosophila melanogaster and humans .
Methodologically, researchers can study BmNDK function through enzyme activity assays measuring phosphate transfer rates or through metabolomic analysis of nucleotide pools in parasites with modified NDK expression.
-
What is the expression pattern of BmNDK throughout the parasite's life cycle?
BmNDK demonstrates constitutive expression throughout all stages of parasite development. Research has confirmed this expression pattern through:
-
RT-PCR analysis showing transcription in all developmental stages
-
Western blot analysis using anti-BmNDK antibodies that specifically recognize a 17.5-kDa molecule in extracts from both adult and larval parasites
This constitutive expression pattern suggests the enzyme plays a fundamental role in parasite survival across all life stages, making it a potential target for intervention at multiple points in the parasite life cycle.
Table 1: BmNDK Expression Across Parasite Life Stages
Life Stage Transcription Protein Detection Molecular Weight Adult male Positive Positive 17.5 kDa Adult female Positive Positive 17.5 kDa Microfilariae Positive Positive 17.5 kDa Infective larvae (L3) Positive Positive 17.5 kDa -
-
How can recombinant BmNDK be produced for research purposes?
Production of recombinant BmNDK can be achieved through the following methodological approach:
-
Isolation of mRNA from B. malayi (preferably from infective stage larvae)
-
cDNA synthesis using reverse transcription with primers targeting the conserved 22-nucleotide spliced leader (SL) sequence that is trans-spliced to the 5' end of nematode transcripts
-
PCR amplification of the BmNDK coding sequence
-
Cloning into an appropriate expression vector (typically with an affinity tag)
-
Transformation into a bacterial expression system (E. coli)
-
Induction of protein expression
-
Purification using affinity chromatography followed by size exclusion chromatography if needed
-
Verification of recombinant protein identity through Western blotting with anti-BmNDK antibodies
This approach has been successfully used to produce functionally active recombinant NDKs from various parasitic organisms and can be adapted specifically for BmNDK.
-
-
How does BmNDK differ structurally from human NDK?
Molecular modeling of BmNDK has revealed several regions surrounding the conserved catalytic site that differ from the human homolog . These structural differences include:
-
Unique amino acid compositions in regions flanking the active site
-
Differences in surface charge distribution
-
Variation in binding pocket geometry
These structural distinctions are particularly significant as they provide potential targets for the design of selective inhibitors that could disrupt NTP synthesis in filarial parasites without affecting human NDK function .
Structural analysis can be performed through X-ray crystallography or homology modeling based on the known structures of NDKs from related organisms, followed by molecular dynamics simulations to identify stable conformations.
-
-
What techniques are available for assessing BmNDK enzymatic activity?
Several methodological approaches can be used to assess BmNDK enzymatic activity:
-
Coupled enzyme assays: The production of ATP can be linked to luciferase activity, generating a luminescent signal proportional to NDK activity
-
Radioactive assays: Using [γ-32P]ATP as a phosphate donor and measuring the transfer to nucleoside diphosphate acceptors
-
HPLC analysis: Direct measurement of nucleotide conversion rates
-
Colorimetric phosphate detection: Measuring released inorganic phosphate during the reaction
When characterizing BmNDK activity, researchers should evaluate:
-
Substrate preferences (optimal nucleoside diphosphate acceptors)
-
Kinetic parameters (Km, Vmax, kcat)
-
Cofactor requirements (typically Mg2+)
-
pH and temperature optima
-
Sensitivity to potential inhibitors
-
